162 related articles for article (PubMed ID: 26912475)
1. Interleukin-33 Expression Indicates a Favorable Prognosis in Malignant Salivary Gland Tumors.
Rössle M; Cathomas G; Bonapace L; Sachs M; Dehler S; Storz M; Huber G; Moch H; Junt T; Mertz KD
Int J Surg Pathol; 2016 Aug; 24(5):394-400. PubMed ID: 26912475
[TBL] [Abstract][Full Text] [Related]
2. BSND is a Novel Immunohistochemical Marker for Oncocytic Salivary Gland Tumors.
Shinmura K; Kato H; Kawanishi Y; Kamo T; Inoue Y; Yoshimura K; Sugiyama K; Misawa K; Hosokawa S; Mineta H; Sugimura H
Pathol Oncol Res; 2018 Apr; 24(2):439-444. PubMed ID: 28470573
[TBL] [Abstract][Full Text] [Related]
3. Salivary Heparanase Level Is a Potential Biomarker to Diagnose and Prognose the Malignant Salivary Gland Tumor.
Wu X; Yu J; Gao G; Wang X; Liu Y; Zhu S; Gong Z
PLoS One; 2015; 10(11):e0143009. PubMed ID: 26569485
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of MUC1 predicts poor survival in salivary gland mucoepidermoid carcinoma.
Liu S; Ruan M; Li S; Wang L; Yang W
J Craniomaxillofac Surg; 2014 Dec; 42(8):1891-6. PubMed ID: 25187376
[TBL] [Abstract][Full Text] [Related]
5. A retrospective review of 139 major and minor salivary gland tumors.
Trenkić Božinović M; Krasić D; Katić V; Krstić M
Med Glas (Zenica); 2015 Feb; 12(1):73-8. PubMed ID: 25669341
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 expression in malignant salivary gland tumors.
Harada K; Ferdous T; Ueyama Y
BMC Cancer; 2018 Feb; 18(1):156. PubMed ID: 29409471
[TBL] [Abstract][Full Text] [Related]
7. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.
Fonseca FP; Sena Filho M; Altemani A; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Feb; 45(2):101-10. PubMed ID: 25990369
[TBL] [Abstract][Full Text] [Related]
8. Implications of methylation patterns of cancer genes in salivary gland tumors.
Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK
Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.
Fonseca FP; Bingle L; Santos-Silva AR; Lopes MA; Coletta RD; de Andrade BA; Mariano FV; Kowalski LP; Rangel AL; Martins MD; Meurer L; Hunter KD; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Oct; 45(9):672-681. PubMed ID: 26991799
[TBL] [Abstract][Full Text] [Related]
10. Expression of the adenocarcinoma-related antigen recognized by monoclonal antibody 44-3A6 in salivary gland neoplasias.
Bentz BG; Haines GK; vonSchlegell AS; Elseth KM; Hanson DG; Radosevich JA
Otolaryngol Head Neck Surg; 1998 May; 118(5):603-9. PubMed ID: 9591857
[TBL] [Abstract][Full Text] [Related]
11. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
Yamazaki M; Fujii S; Murata Y; Hayashi R; Ochiai A
Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological and clinical characteristics of 705 salivary glands neoplasms].
Ziółkowska M; Bień S; Okła S; Zyłka S
Otolaryngol Pol; 2013; 67(3):154-63. PubMed ID: 23719273
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of O-6-methylguanine-DNA methyltransferase loss in salivary gland carcinomas.
Scesnaite A; Jarmalaite S; Mueller M; Agaimy A; Zenk J; Hartmann A; Iro H; Peters B; Schwarz S; Schneider-Stock R
Head Neck; 2014 Sep; 36(9):1258-67. PubMed ID: 25201059
[TBL] [Abstract][Full Text] [Related]
14. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of WT1 in epithelial salivary tumors.
Leader R; Deol-Poonia RK; Sheard J; Triantafyllou A
Pathol Res Pract; 2014 Nov; 210(11):726-32. PubMed ID: 25086675
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland tumors among atomic bomb survivors, 1950-1987.
Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
[TBL] [Abstract][Full Text] [Related]
18. EZH2 is a sensitive marker of malignancy in salivary gland tumors.
Hajósi-Kalcakosz S; Vincze E; Dezső K; Paku S; Rókusz A; Sápi Z; Tóth E; Nagy P
Diagn Pathol; 2015 Sep; 10():163. PubMed ID: 26377323
[TBL] [Abstract][Full Text] [Related]
19. [Malignant salivary gland tumors. Effect of histology and site on prognosis].
Chilla R; Casjens R; Eysholdt U; Droese M
HNO; 1983 Aug; 31(8):286-90. PubMed ID: 6629867
[TBL] [Abstract][Full Text] [Related]
20. Salivary gland tumors: a 10-year retrospective study of survival in relation to size, histopathological examination of the tumor, and nodal status.
Dorairajan N; Periyasamy S; Muthayya P; Manikandan R; Srinivasan T; Siddharth D
Int Surg; 2004; 89(3):140-9. PubMed ID: 15521250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
